On 27 Sep 2021, the IMI Consortium IDEA-FAST submitted a request for an initial CHMP (Committee for Medical Products for Human Use) qualification advice to discuss the results of the Feasibility Study and acceptability […]
One of the ways we ensure that the patient voice is heard and put at the centre of the project in all its stages is by having monthly meetings with representatives of several patients organisations […]
We are pleased to welcome Ioannis Pandis as the Interim Project Lead for IDEA-FAST, who is taking over the role from Fred Baribaud. Ioannis is already contributing to the project as the Industry Lead […]
The Innovative Medicines Initiative (IMI) has shared the latest joint vision from MOBILISE-D and IDEA-FAST to strengthen R&D in the area of remote monitoring! Read the news here: https://www.imi.europa.eu/news-events/newsroom/digital-biomarkers-initiative-help-researchers-navigate-new-reality-roles […]
The 2nd General Assembly was held as a virtual meeting on 8th – 9th March 2021, with around 130 participants from all partners as well as external members of the Scientific Advisory Board and the Patient Specialist […]
Mobilise-D is working on digital mobility assessment in chronic obstructive pulmonary disease (COPD), Parkinson’s disease (PD), multiple sclerosis (MS) and recovery from proximal femoral fracture (PFF). IDEA-FAST is working to identify digital endpoints to […]
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.